The regulated loading of the Mcm2-7 DNA helicase (comprising six related subunits, Mcm2 to Mcm7) into pre-replicative complexes at multiple replication origins ensures precise once per cell cycle replication in eukaryotic cells. The origin recognition complex (ORC), Cdc6 and Cdt1 load Mcm2-7 into a double hexamer bound around duplex DNA in an ATP-dependent reaction, but the molecular mechanism of this origin 'licensing' is still poorly understood. Here we show that both Mcm2-7 hexamers in Saccharomyces cerevisiae are recruited to origins by an essential, conserved carboxy-terminal domain of Mcm3 that interacts with and stimulates the ATPase activity of ORC-Cdc6. ATP hydrolysis can promote Mcm2-7 loading, but can also promote Mcm2-7 release if components are missing or if ORC has been inactivated by cyclin-dependent kinase phosphorylation. Our work provides new insights into how origins are licensed and reveals a novel ATPase-dependent mechanism contributing to precise once per cell cycle replication.
Stable genome inheritance requires that replication origins initiate efficiently during S phase, and that re-initiation from these origins is subsequently prevented. This is accomplished by first licensing origins during G1 phase with a pre-replicative complex containing an inactive double hexamer of the Mcm2-7 helicase, and then activating the helicase during S phase, when pre-replicative complexes can no longer be assembled [1] [2] [3] [4] [5] [6] [7] [8] [9] .
Mcm3 recruits Cdt1-Mcm2-7 to ORC-Cdc6
We have previously described a system in which pre-replicative complexes can be assembled on DNA with purified proteins 7 . When ATP is present, ORC and Cdc6 load Cdt1-Mcm2-7 heptamers into a saltresistant Mcm2-7 double hexamer with concomitant release of Cdc6 and Cdt1; in ATP-cS (a slowly hydrolysed analogue of ATP) all prereplicative complex components are recruited in low salt but are removed by a high-salt wash (HSW) ( Supplementary Fig. 1a ). To investigate the individual roles of Cdt1 and Mcm2-7, we purified each separately ( Supplementary Fig. 1b-d ) and showed each protein was functional for loading when re-assembled into a Cdt1-Mcm2-7 complex ( Supplementary Fig. 2 ). Consistent with our previous results 7 , none of the pre-replicative complex components bound to DNA under recruitment conditions (ATP-cS, low salt) in the absence of ORC (Fig. 1A, lanes 1-6) . In the absence of Cdc6 (lanes 7-9), ORC bound DNA, but could not recruit Cdt1, Mcm2-7 or Cdt1-Mcm2-7. Cdc6 was recruited to DNA in an ORC-dependent manner (compare lanes 4 and 10) consistent with the formation of an essential ORC-Cdc6 complex 10 . Cdt1 was not recruited in the presence of ORC-Cdc6 (lane 10), but we found significant ORC-and Cdc6-dependent recruitment of Mcm2-7 subunits in the absence of Cdt1 (compare lane 11 to lanes 6 and 9). Cdt1 was only recruited when Mcm2-7 was present along with ORC and Cdc6 (lane 12). From this we conclude that Mcm2-7 can be recruited to ORC-Cdc6 without Cdt1 and that Cdt1 recruitment requires Mcm2-7.
The absence of Cdt1 did not affect Mcm7 recruitment, but did reduce the amount of Mcm2 recruited (Fig. 1A, compare lanes 11  and 12) . To explore this further, we tested for the presence of each of the six Mcm2-7 subunits after Mcm2-7 recruitment in ATP-cS in the presence or absence of Cdt1 using silver staining (Fig. 1B, a) and immunoblotting ( Fig. 1B, b ). We found that Mcm3, 5 and 7 were recruited to ORC-Cdc6 similarly in the presence and absence of Cdt1 (Fig. 1B) ; the recruitment of Mcm2, 4 and 6, however, was significantly reduced without Cdt1. This suggests that Mcm3, 5 and 7, which are immediate neighbours in the Mcm2-7 ring, are recruited to ORC-Cdc6 directly without Cdt1, but Cdt1 plays some role in recruiting Mcm2, 4 and 6 ( Fig. 1B, c) .
The extreme C terminus of Mcm3 recruits Cdt1-Mcm2-7
We took several approaches to address which Mcm2-7 subunits were involved in the Cdt1-independent recruitment. We tested each of the six Mcm2-7 subunits individually and found that only Mcm3 could be recruited in a Cdc6-dependent manner without the other subunits ( Supplementary Fig. 3a , b, f). We next assembled Mcm2-7 complexes containing all subunit or lacking either Mcm3 or Mcm4 (D3 and D4, respectively; Supplementary Fig. 3c, d ). Mcm5 and 7 were recruited to ORC-Cdc6 in the absence of Cdt1 by the complete complex ( Supplementary Fig. 3f , lanes 1 and 5) and by D4 (lanes 3 and 7), but not by D3 (lanes 2 and 6). Taken together, these results indicate that Mcm3 is critical for recruiting Mcm5 and 7 to ORC-Cdc6 in the absence of Cdt1.
Mcm3 comprises an amino-terminal domain (NTD) and a AAA1 domain, which are both found in all Mcm2-7 subunits 11, 12 , and an extended C-terminal tail of unknown function containing a conserved domain at the extreme C terminus ('C' in Fig. 2a ) that is not found in other Mcm2-7 subunits ( Fig. 2a ). A version of Mcm3 containing a 33Flag tag at its C terminus could be assembled into a stable heptameric Cdt1-Mcm2-7 complex, but was unable to recruit or load Mcm2-7 ( Supplementary Fig. 4 ). Moreover, a small fragment containing the C-terminal 194 amino acids residues of Mcm3 was recruited in an ORC-and Cdc6-dependent manner (Fig. 2b) . These results pointed to the C terminus as being crucial for Mcm3 recruitment.
Based on the conservation of the Mcm3 C terminus ( Fig. 2a ), and the fact that a tag at the C terminus interfered with its function, we generated a series of C domain amino acid substitution mutants in full-length Mcm3 (Fig. 2a ). We assembled the mutant proteins into Fig. 1A, B ) therefore probably reflects a role for Cdt1 in retaining or stabilizing these subunits after initial recruitment by Mcm3.
We next expressed the mutant Mcm3 proteins in yeast strains harbouring a temperature-sensitive degron mutant of MCM3 (mcm3-td) 13 . This degron mutant grew well at 25 uC, but not at the restrictive temperature, 37 uC ( Fig. 2e , row 1). The growth defect at 37 uC was suppressed by expression of wild-type Mcm3 (Mcm3, row 2), but not by expression of indicating that these proteins are not functional in vivo. Expression of these proteins significantly reduced growth even at 25 uC when the wild-type degron fusion protein was functional (middle panel, GAL 25 uC, compare row 1 with rows 3-5), indicating that these mutants act as dominant-negative inhibitors when overexpressed. Some of the other mutants (Mcm3-16, Mcm3-22, Mcm3-23) showed mild growth defects at 37 uC, consistent with their partial defects in Mcm2-7 loading. Supplementary Fig. 7 shows that mcm3-11 supported only very slow growth when present as an only copy, whereas mcm3-12 and mcm3-13 did not support growth. Taken together, these results indicate that a domain at the extreme C terminus of Mcm3 is necessary for recruiting Cdt1/Mcm2-7 to ORC-Cdc6, and that this function is essential for viability.
Both Mcm2-7 hexamers require the C terminus of Mcm3
The results in Figs 1 and 2 show that recruitment of the first Mcm2-7 hexamer occurs by interaction of Mcm3 with ORC-Cdc6. If recruitment of the second hexamer occurred by a different mechanism, one that didn't involve Mcm3-ORC-Cdc6 interaction but did require recruitment of the first hexamer, then the Mcm3-11 mutant should be able to be recruited as the second hexamer in the presence of wildtype Cdt1-Mcm2-7. To test this, we first generated two different forms of Mcm3 that could be distinguished after SDS-polyacrylamide gel electrophoresis (SDS-PAGE), one containing an N-terminal fusion to the Flag tag (N9 33Flag-Mcm3), the other containing a larger N-terminal fusion to maltose binding protein (N9 MBP-Mcm3). Both proteins supported similar levels of recruitment and loading, and both complemented the mcm3-td mutant at 37 uC ( Supplementary  Fig. 8 ). We engineered the Mcm3-11 mutation into either the MBP fusion ( Fig. 3a ) or the Flag fusion ( Fig. 3b ), generated mutant Cdt1-Mcm2-7 complexes and mixed these complexes in different ratios with Cdt1-Mcm2-7 containing either wild-type Flag-Mcm3 ( Fig. 3a ) or wild-type MBP-Mcm3WT (Fig. 3b) . These experiments show that the Mcm3-11 mutant was not recruited above background levels in ATP or ATP-cS over a wide range of wild type:mutant ratios, showing that the wild-type protein cannot aid recruitment of the Mcm3-11 mutant complex, indicating that recruitment of both hexamers requires the Mcm3 C terminus.
Mcm3 binding activates the ORC-Cdc6 ATPase
ATP hydrolysis is required for assembly of the Mcm2-7 double hexamer, but what stage of assembly requires ATP hydrolysis is not known. We therefore tested whether Mcm3 binding affected the ATPase activity of DNA-bound ORC-Cdc6. Neither Mcm3 nor the Mcm3-13 mutant showed appreciable ATPase activity by themselves ( Fig. 4a ), consistent with the fact that, as a AAA1 ATPase, Mcm3 requires an arginine finger from a binding partner (in this case, Mcm5) to promote ATP hydrolysis. ORC, together with Cdc6 (ORC-Cdc6, Fig. 4a ), had some ATPase activity in the presence of DNA, which might reflect a basal level of ATPase from DNA-bound ORC-Cdc6, or might be caused by ORC and/or Cdc6 that is not bound to DNA. Addition of Mcm3, but not Mcm3-13, to ORC-Cdc6 resulted in a three-to fourfold increase in ATPase activity, indicating that the interaction of the C terminus of This could be because the remaining Mcm2-7 subunits cannot form stable, topologically closed double hexamers around DNA and are, therefore, released during a futile loading reaction with ATP hydrolysis. ORC is not required for Mcm2-7 to remain bound topologically to the DNA after loading (for example, after a high-salt wash). So, we next looked at the ability of the full, wild-type Cdt1-Mcm2-7 complex to be recruited and loaded by ORC lacking the Orc6 subunit (ORCD6), which can still bind DNA 14 . ORCD6 was able to recruit all six Mcm2-7 subunits in the presence of ATP-cS as 
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efficiently as the complete ORC complex (Fig. 5c, lanes 3 and 4) . Although the recruited complex was slightly more salt-sensitive than the complex recruited with the complete ORC complex (Supplementary Fig. 9b ), the only significant difference between Fig. 5c lanes 3 Supplementary  Fig. 9d, lane 4) . Notably, although ORCD6 recruited all six Mcm2-7 subunits in ATP-cS, it was unable to stably recruit any of these subunits in the presence of ATP (compare Fig. 5c, lanes 2 and 4) . ORCD6 and Cdc6 are bound equally well in ATP and ATP-cS (Supplementary Fig. 9a ). Thus, although the entire Mcm2-7 ring is efficiently recruited, ATP hydrolysis promotes release of Cdt1-Mcm2-7 in the absence of Orc6.
To rule out the possibility that the non-physiological absence of Orc6 somehow alters the function of ORC-Cdc6, and to examine the role of ATP-dependent Mcm2-7 release in vivo, we examined a physiologically relevant situation where ORC has been functionally inactivated. Phosphorylation of Orc6, along with Orc2, by cyclindependent kinase (CDK) plays a role in preventing re-replication 15, 16 by blocking the ability of ORC to load Mcm2-7 17 . We phosphorylated purified ORC (ORC-P) with the yeast mitotic CDK, Clb2-Cdc28, and examined its ability to recruit and load Mcm2-7. ORC-P cannot load Mcm2-7 (Fig. 5d, compare lanes 2 and 6) , but it can recruit Mcm2-7 subunits as well as the unphosphorylated ORC in the presence of ATP-cS (compare lanes 3 and 7). However, ORC-P was unable to accumulate Mcm2-7 subunits in the presence of ATP (compare lanes 1 and 5). Lambda phosphatase treatment of ORC-P restored its ability to recruit and load Mcm2-7 in ATP (Fig. 5d, lanes 9-12) . These results show that, as in the cases of Mcm3 alone, Mcm2-7 without Cdt1, and ORCD6, the CDK-phosphorylated ORC is competent to recruit Mcm2-7 to ORC-Cdc6, but ATP hydrolysis then promotes Mcm2-7 release.
To provide additional evidence that ATP hydrolysis can promote Mcm2-7 release from ORCD6, we have looked at Mcm2-7 recruitment in ATP at reduced temperatures, to slow ATP hydrolysis. In contrast to 30 uC (Fig. 5c ), the recruitment of Mcm2-7 by ORCD6 occurred equally well in ATP and ATP-cS at 8 uC ( Supplementary  Fig. 10 ). However, when these reactions were shifted to 30 uC after 9 min, recruitment of Mcm2-7 continued in ATP-cS but Mcm2-7 was significantly reduced in the presence of ATP, consistent with the idea that elevated temperature promotes ATP hydrolysis and subsequent Mcm2-7 dissociation.
Discussion
Our results support a model for origin licensing wherein Cdt1-Mcm2-7 is first recruited to origins by interaction between the C terminus of Mcm3 and ORC-Cdc6 ( Fig. 5e step 3 ). Cdt1 is not required for this initial recruitment, in contrast to previous experiments in crude extracts [17] [18] [19] . We suggest, by analogy to other AAA1 proteins 20 , that domain movements in ORC-Cdc6 triggered by Mcm3 binding activate the ATPase of ORC and/or Cdc6 by bringing arginine fingers in contact with ATP binding sites in adjacent subunits ( Fig. 5e step 4) . We further suggest that these domain movements are transmitted to Mcm2-7, leading to destabilization of Mcm2, Mcm4 and Mcm6 when Cdt1 is missing (Fig. 1A, B ). Cdt1 stabilizes Mcm2-7 
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in this new conformation by a mechanism that does not require its interaction with Orc6 (Fig. 5c ). Because both hexamers must interact with ORC-Cdc6 (Fig. 3) , our results indicate they are either loaded sequentially or there is more than one Mcm3 binding site in ORC-Cdc6, allowing concerted loading. When all pre-replicative complex components are present and in the correct post-translational modification state, ATP hydrolysis promotes loading of the ring around DNA (Fig. 5e step 5 ). However, when criteria for correct licensing are not met, ATP hydrolysis instead is coupled to irreversible dissociation of inappropriate protein assemblies, preventing the accumulation of non-productive complexes ( Fig. 5e step 6 ). Cdc6 is bound to ORCD6 in both ATP and ATP-cS ( Supplementary Fig. 9e ), indicating either that Cdc6 remains bound to ORC after Cdt1-Mcm2-7 release, or that Cdc6 is released, but rebinds quickly ( Fig. 5e step 7) . This ATPase-dependent quality control mechanism contributes to preventing licensing by CDKphosphorylated ORC outside of G1 phase, and therefore has a role in ensuring once per cell cycle replication. We note that the block to re-replication in metazoans works largely through inhibition and degradation of Cdt1 21, 22 , and our results (Fig. 5b) indicate that this will also prevent licensing via this ATPase-dependent mechanism. Although a great deal is known about the multiple pathways contributing to a robust block to re-assembly of pre-replicative complexes after replication in eukaryotes 23, 24 , few quality control mechanisms contributing to efficient pre-replicative complex assembly during G1 phase have been described (see ref. 25) . The mechanism we have described here may also have a role during G1 phase to ensure assembly of complete, functional pre-replicative complexes.
METHODS SUMMARY
All strains are listed in Supplementary Table 1 and strain constructions are described in Methods. Mcm2-7 loading reactions were performed as described (ref. 7 and Methods). After isolation and washing of the beads, DNA was cleaved from beads using irradiation with a 330 nm light source, which does not induce significant levels of DNA crosslinking (see Methods and Supplementary Fig. 11 ). Proteins were analysed after SDS-PAGE by either silver staining or immunoblotting with a variety of antibodies (Methods). All proteins were expressed in either S. cerevisiae or Escherichia coli and were purified as described in Methods. Cdt1 and Mcm2-7 expressed in both bacteria and yeast were proficient for loading ( Supplementary Fig. 12 ). ATPase assays were based on the method described in ref. 26 with the modifications described in Methods.
Full Methods and any associated references are available in the online version of the paper.
METHODS
Cdt1-Mcm2-7 overexpressed in yeast (yJF38). To obtain a yeast strain overexpressing the Cdt1-Mcm2-7 complex, four new vectors were generated using the pRS30_ series 27 . Making use of the bidirectional inducible GAL1-10 promoter, the six MCM subunits, CDT1 and GAL4 genes were cloned and overexpressed in the strain yJF38. GAL4 is a positive regulator of GAL genes in response to galactose, it was therefore overexpressed together with the MCM2-7 and CDT1 genes to increase protein yield.
GAL4 and MCM2 were amplified using the primer pairs JF1-2 and JF3-4, respectively. GAL4 was cloned into pRS303 (pJF2.1) and MCM2 into pRS306 (pJF5.1) between SmaI and BamHI sites. MCM7 and MCM5 were amplified with JF5-6 and JF7-8 primer pairs and cloned into a SmaI site in pRS304 (pJF4.1) and pRS306 (pJF3.1), respectively. The forward primers inserted a unique AscI site at the 59 end of the start codon of these genes. MCM3, MCM6, MCM4 and CDT1 were amplified using the following primer pairs: JF9-10, JF11-12, JF13-14 and JF15-16. The PCR products were cloned between SpeI and NotI sites into pJF5.1, 4.1, 3.1 and 2.1, respectively, to yield pJF5.2, 4.2, 3.2 and 2.2. In this case, a unique SgrAI site was inserted at the 59 end of their start sites. In addition a 33Flag tag 28 was inserted using a SgrAI site present upstream of MCM3 in pJF5.2 (pJF6.2). Finally, the GAL1-10 promoter was cloned between the AscI and SgrAI sites previously inserted, yielding pJF2, 3, 4 and 6. These vectors were integrated into the strain yJF1 (yJF38). Cdt1-Mcm2-7 overexpressed in yeast (yJF35, yJF59 and yJF73). yJF35 and yJF59 are analogous to yJF38 except that the 33Flag tag on MCM3 was inserted at its C terminus in yJF35 and on the C terminus of CDT1 in yJF59. The vectors integrated into yJF1 were pJF2, 3, 4 and 5. The C-terminal 33Flag on MCM3 and CDT1 was inserted afterwards by PCR-based tagging using pBP83. pJF2, 3, 4 and 39 vectors were integrated into the strain yJF1, yielding yJF73. Mcm2-7 overexpressed in yeast (yJF39). To obtain a Mcm2-7 complex without Cdt1, a strategy similar to the design of yJF38 was followed, except that pJF2 was not integrated into the final strain and the endogenous CDT1 locus was tandem affinity purification (TAP)-tagged 29 using pJF21, thus producing yJF39. ORC overexpressed in yeast (ySD-ORC). To overexpress ORC in yeast, we modified pJF2, 3 and 5 as follows. In pJF5, MCM2 and MCM3 were replaced with calmodulin binding peptide-tobacco etch virus (CBP-TEV)-ORC1 and -ORC2, respectively (pJF19). In pJF2 GAL4 and CDT1 were substituted with ORC3 and ORC4, respectively (pJF17). In pJF3, MCM5 and MCM4 were replaced with ORC5 and ORC6, respectively (pJF18). All ORC genes were codon optimized. Finally, pJF19, 17 and 18 were integrated into yJF1, producing the strain ySD-ORC. ORC(D6) overexpressed in yeast (ySD-ORC(D6)). In pJF3, MCM5 was replaced with ORC5 and MCM4 was deleted, producing the vector pJF20. To obtain ORC without Orc6, yJF1 was transformed with pJF17, 19 and pJF20, instead of pJF18. Furthermore, a C-terminal 33Flag tag was added to the endogenous copy of ORC6, using pBP83. MCM3 mutants. MCM3 mutants were cloned into two different vectors: pMAL-C2P to purify recombinant proteins, and pRS306 for complementation studies in yeast.
pMAL-C2P was a gift from S. Mochida and was derived from pMAL-C2 (NEB) by introducing a PreScission protease site before the EcoRI site in the polylinker region 30 . MCM3 was amplified from S. cerevisiae genomic DNA using AM51 and AM52 and cloned into pMAL-C2P using XbaI and SalI sites (pAM5). MCM2 in pJF5 was removed, to yield pGC003. MCM3 mutant sequences were excised from pJF27, 28, 29, 32, 35 and 36 vectors using AvrII and NotI sites, and cloned into pGC003 (pJF8, 9, 10, 13, 15 and 16) . Mcm2 in pJF6 was removed, to yield pJF37. MBP tag was amplified from pMAL-C2P using the primers JF19 and 20 and cloned into pGC003 using SgrAI unique site, originating pJF38. Finally, these vectors were integrated into a MCM3 degron strain (yKL43 13 ), producing the strains yJF63, 64, 65, 66, 69, 71, 72, 78 and 79. MCM3 mutants in a diploid background. Wild-type C-terminal Mcm3 was amplified from pGC003, C-terminal Mcm3 mutants were amplified from pJF27 (Mcm3-11), pJF28 (Mcm3-12) and pJF29 (Mcm3-13) using primers JF17 and JF18. The PCR products contained the URA3 gene and were used to transform the diploid strain W303 (all amplified products were sequenced before transformation). Transformants were selected for on media lacking uracil. These were shown by PCR to be heterozygous for replacement of the C terminus of over a 1 ml MonoQ 5/50 GL column (GE Healthcare) using an elution gradient of 0.15-0.5 M KCl over 10 column volumes. Peak fractions containing ORC were pooled, dialysed against buffer C/0.3 M K-acetate and stored in aliquots. Purification of ORC(D6) from ySD-ORC(D6). To purify ORC without Orc6, a similar protocol to the purification of ORC was followed, except that Flag immunoprecipitation of endogenous Orc6 was included, to remove complexes containing Orc6 ( Supplementary Fig. 9c ). This was performed as follows: pooled fractions from the gel filtration were incubated for 30 min at 4 uC with 1 ml packed bead volume of anti-Flag M2 agarose (Sigma). Flow-through was collected and concentrated over a MonoQ 5/50 GL column (GE Healthcare), as described for the purification of ORC. Proteins expressed in bacteria. All expression plasmids were transformed into BL21 DE3 Codon1 RIL cells (Stratagene) (unless indicated). 3 l of cells (unless indicated) were grown at 37 uC to a density of D 600 nm 5 0.5-0.8. Cells were chilled on ice, and then IPTG was added to 1 mM. Induction was carried out overnight at 18 uC. To purify these proteins, we followed the protocol described in ref. 31 . The starting cultures were 3 l in volume. Purification of Mcm5. Cells were grown and expressed as described above. Cells were collected, washed once with ice-cold 25 mM HEPES-KOH pH 7.6/1 M sorbitol, once with buffer E (50 mM Tris-HCl pH 7.5, 0.05% NP-40, 10% glycerol, 1 mM EDTA and 1 mM DTT)/1 M NaCl, and the pellet was resuspended in 40 ml of buffer E/1 M NaCl/protease inhibitors (Roche). Cells were sonicated and the lysate centrifuged as described for the purification of MBP-Mcm3. The soluble fraction from centrifugation was treated with 0.3 g ml 21 ammonium sulphate, and stirred for 20 min at 4 uC. The mixture was centrifuged at 17,000 r.p.m. (34,600g) for 20 min. The pellet was resuspended in 40 ml of buffer E containing 0.25 g ml 21 of ammonium sulphate and centrifuged as before. This was repeated with 0.20 mg ml 21 ammonium sulphate. The pellet was resuspended in 30 ml of buffer E and dialysed against buffer E for one hour at 4 uC. After checking that the conductivity of the sample was below that of buffer E/0.1 M NaCl, the sample was applied to a 5 ml FF Q column (GE Healthcare), pre-equilibrated in buffer E/0.1 M NaCl. Elution was done using a gradient of 0.1 M to 0.5 M NaCl over 10 column volumes. Peak fractions were pooled and diluted down to a conductivity below that of buffer E/0.1 M NaCl. The sample was then applied to a 5 ml Heparin column (GE healthcare) pre-equilibrated in buffer E/0.1 M NaCl. Flow through was collected and subjected to fractionation over an 8 ml MonoQ column (GE Healthcare). Elution was performed using a gradient of 0.1 M to 0.5 M NaCl over 20 column volumes. Peak fractions were collected and subjected to fractionation over a Superdex 200 10/300 GL column (GE Healthcare) preequilibrated with buffer E/0.3 M NaCl. Peak fractions were pooled, concentrated using a Microcon YM-10, 10000 MWCO (Millipore) and aliquoted. Purification of Mcm4. 3 l of expressing cells were grown and we followed the purification process described in ref. 31 . At the end of the described protocol, we introduced an extra gel filtration step using a Superdex 200 10/300 GL column (GE Healthcare), pre-equilibrated in buffer E/0.3 M NaCl. Purification of Mcm6. To purify Mcm6, the same protocol as that described for Mcm5 was followed, the difference being that Mcm6 was bound to a 5 ml heparin column (GE Healthcare). Bound protein was eluted using a gradient of 0.1 to 0.5 M NaCl over 20 column volumes. Peak fractions were pooled and the conductivity was reduced to below that of buffer E/0.1 M NaCl. The sample was then applied to an 8 ml MonoQ column (GE Healthcare), as described in the purification of Mcm5. Purification of Cdt1. Expressing cells were grown and induced as described before. Cells were collected, washed with PBS pH 7.5, and then washed with buffer F (PBS pH 7.5, 10% glycerol, 1 mM DTT and 0.3 M NaCl). The pellet was resuspended in 40 ml of buffer F/protease inhibitors (Roche) and sonicated 3 3 30 s using a sonicator Soniprep 150 (Sanyo) at 15 microns. Lysate was centrifuged at 45,000 r.p.m. (235,400g) for 60 min using a Ti45 rotor. 2 ml of packed bead volume glutathione Sepharose 4Fast Flow (GE Healthcare) were added to the soluble phase and incubated for 2.5 h at 4 uC. The solution was centrifuged at 3,000 r.p.m. (1,400g) for 3 min, beads were collected, 10 column volumes of buffer F were added, and the mixture was incubated for 10 min at 4 uC. This wash step was repeated with 20 column volumes of buffer F, and 10 column volumes of buffer E/0.3 M NaCl). The pellet was then resuspended in 2 ml of buffer E/0.3 M
